Articles

The final countdown

As the weeks and days tick off in preparation for the final SBS Annual Conference and Exhibition, organizers prepare to usher in the first annual SLAS Conference and Exhibition
Written byJeffrey Bouley
| 12 min read

ORLANDO, Fla.—Calling the SBS 17th Annual Conference and Exhibition "a catalytic launching pad to our future as a united organization," Michelle Palmer, president of the Society for Laboratory Automation and Screening (SLAS), notes that while this is last Society for Biomolecular Sciences (SBS) conference, "we have not taken a 'farewell' approach," adding that in quite the opposite vein, the organizers have invested more time, energy and money into the event than ever before.

"We're very excited about this Orlando meeting," notes Greg Dummer, the CEO of SLAS and formerly the head of the Association for Laboratory Automation (ALA), which merged this year with SBS to form SLAS. "It's my first time in the management seat working with an event aimed at the SBS members, and we've seen exhibitors really respond as well as seeing PerkinElmer come to the table as a premier sponsor. Plus, there is a very high quantity and quality of people coming through the educational arm of the event. I feel this will truly be one of our finest shows and great launching pad into SLAS2012."

Dummer admits that it is hard right now to pin down accurate predictions as to attendance numbers, given that early-bird registration only closed on Jan. 24, just a few days after he spoke with ddn, but he is optimistic. Lead indicators of registration and exhibit floor sales are all "tracking according to historical markers," he says, and he expects registrations to be on par with past years and for the exhibit floor to be sold out.

With the Palm Springs, Calif., meeting of the ALA—LabAutomation2011—just about to start as he spoke with ddn, Dummer noted that it and the Orlando meeting are critical to SLAS in terms of taking a hard look at how to increase vitality for the former ALA and former SBS members and to keep anticipating exhibitor needs as well going into 2012.

In some ways, he says, the SBS meeting is a test bed for some of those changes, given that the exhibit hall hours were reconfigured this year compared to previous years, and the floor design itself was revamped to make it more "friendly and accessible." That has included investments into technology and programming to enhance connectivity and networking, as well as having more food and beverage functions.

"We've also instituted free exhibit hall-only passes, which in previous years cost $200," Dummer adds. "We decided to take a proactive approach for our constituents, who are a very important part of our organization, and make this meeting something that was much more efficient, engaging, enjoyable and educational for them."

The educational part, he points out, is as much a key to the event's success as the exhibitions, and more funds were invested for academic travel awards and travel fees for speakers. He and his team also brought in an innovation that ALA has used in recent years—a flight discount program under which the first 50 registrants get $200 off the cost of their flights. Also, complimentary waivers have been provided for unemployed individuals.

All of those pricing strategies—among others—are something that Dummer says is the third leg of the stool, along with the exhibitors and the educational program.

"As part of our revitalized commitment to young scientists, we have invested in the next generation by allocating $20,000 to bring students from around the world to our Orlando event," says Palmer, referring to the academic travel awards. "Also, because the job outlook is of particular concern for us, we've implemented a significant discount program and added a new group pricing structure in addition to the waiver for unemployed professionals."

She adds that free career counseling by appointment is available to all participants while on-site, which will be useful to the employed, underemployed and unemployed alike.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D illustration of a single cell surrounded by small molecular particles in a red biological environment.
Measuring mRNA and protein together at single cell resolution can uncover tumor-specific signaling activity and immune features.
Illustration of an antibody intertwined with a DNA double helix.
Discover how CRISPR and single-cell RNA sequencing can connect disease-associated variants to regulatory elements, genes, and pathways.
Digital illustration of the human digestive system highlighting the liver, stomach, and intestines.
Explore how human gut-liver models can improve the translation of preclinical findings into clinical pharmacokinetic predictions.